2'-O-MOE Nucleosides
5'-DMT-2'-O-MOE-N4-acetylcytidine
Quick view. We supply 5'-DMT-2'-O-MOE-N4-acetylcytidine as a 2'-O-MOE nucleoside for antisense oligonucleotide monomer and analog synthesis. CAS 1345716-47-3. Catalog target purity: Specification on request.
Structure and identity
The structure drawing for this item is being finalized. Use the CAS number and machine-readable identifiers below to confirm the requested protecting groups, stereochemistry, salt or counterion and hydration state before ordering.
CAS, molecular formula, SMILES or InChI data are shown below when available.
We withhold a drawing when a related compound, alternate salt or incompletely specified stereoisomer could be mistaken for the requested material.
Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.
Product profile
5'-DMT-2'-O-MOE-N4-acetylcytidine is classified as nucleoside or protected nucleoside intermediate (Formula C35H39N3O9; molecular weight 645.71).
5'-DMT-2'-O-MOE-N4-acetylcytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 5'-DMT-2'-O-MOE-N4-acetylcytidine, mOE placement needs design control, especially when RNase H recruitment or steric profile matters.
Names and search terms
Confirmed or normalized name variants
- N4-Acetyl-5’-O-DMTr-2’-O-methoxyethyl-cytidine
- Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-
Useful catalog search terms
- CAS 1345716-47-3
- Nucleoside or protected nucleoside intermediate
- DMTr/DMT protection
- 2'-O-MOE modification
- 2'-O-MOE Nucleosides
Physicochemical data
| Key chemistry motifs | DMTr/DMT protection; 2'-O-MOE modification |
|---|---|
| Density | 1.27±0.1 g/cm3(Predicted) |
| pKa | 10.19±0.20(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Product-specific evaluation notes
Potential advantages
- 2′-O-MOE motifs are often selected for enhanced nuclease resistance and improved duplex stability.
Method limitations
- MOE placement needs design control, especially when RNase H recruitment or steric profile matters.
These points describe 5'-DMT-2'-O-MOE-N4-acetylcytidine or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
2'-O-MOE-rI
2'-O-MOE Nucleosides · CAS: 545374-76-3
BX-MN-01672'-O-MOE-5-Me-rC
2'-O-MOE Nucleosides · CAS: 244105-55-3
BX-MN-01682'-O-MOE-rG
2'-O-MOE Nucleosides · CAS: 473278-54-5
BX-MN-01692'-O-MOE-rA
2'-O-MOE Nucleosides · CAS: 168427-74-5
BX-MN-01702'-O-MOE-rC
2'-O-MOE Nucleosides · CAS: 223777-16-0
BX-MN-01712'-O-MOE-rU
2'-O-MOE Nucleosides · CAS: 223777-15-9
Frequently asked questions
Can the package size for 5'-DMT-2'-O-MOE-N4-acetylcytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-2MOE-0003 and CAS 1345716-47-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the 2'-O-MOE Nucleosides product family and its named chemistry.